Dyspnea Case Discussion: An Approach to Evaluating Dyspnea
This case discussion provides a structured approach to evaluating dyspnea in adult internal medicine patients. It focuses on building a differential diagnosis, identifying appropriate diagnostic studies, and correlating pathophysiology with patient presentation and treatment options.
The case presents a 65-year-old male with a history of hypertension, hyperlipidemia, coronary artery disease, type 2 diabetes, and chronic kidney disease who presents with acute dyspnea. His symptoms include rapid onset of shortness of breath, orthopnea, worsening leg edema, and a frequent cough. He denies chest pain, palpitations, fevers, or chills.
The patient's medications include aspirin, lisinopril, hydrochlorothiazide, amlodipine, atorvastatin, and metformin. He has a history of smoking (30 pack-years) and a family history of stroke, hypertension, breast cancer, and coronary artery disease. Socially, he is a retired construction manager who lives alone and is independent in his ADLs. Physical exam findings include elevated blood pressure (195/110), elevated heart rate (95), respiratory rate of 25, oxygen saturation of 85% on room air, elevated JVP (15cm), dullness at the bases with crackles up to the mid-lung field bilaterally, and 2+ edema to the shins bilaterally.
A problem list should include acute dyspnea, hypertension, hyperlipidemia, coronary artery disease, type 2 diabetes, chronic kidney disease, obesity (BMI 38), and history of tobacco use.
The differential diagnosis for acute dyspnea in this patient should include acute decompensated heart failure, acute coronary syndrome (ACS), pulmonary embolism (PE), pneumonia, and chronic obstructive pulmonary disease (COPD) exacerbation. Other less likely but potentially relevant considerations include acute kidney injury and medication side effects.
Initial workup should include a complete blood count (CBC), basic metabolic panel (BMP), cardiac enzymes (troponin), B-type natriuretic peptide (BNP), D-dimer, chest X-ray (CXR), and electrocardiogram (ECG). Arterial blood gas (ABG) should also be considered to assess oxygenation and acid-base status.
The patient's laboratory data reveals elevated troponin levels (150 -> 180 -> 175), significantly elevated NT-proBNP (1350), and a slightly elevated creatinine (1.7). The D-dimer is also elevated (200). These findings suggest acute cardiac injury (ACS), heart failure, and possible pulmonary embolism.
Given the patient's presentation and lab results, the most likely diagnosis is acute decompensated heart failure secondary to acute coronary syndrome. The elevated troponin suggests myocardial damage, while the elevated BNP supports the diagnosis of heart failure. The elevated D-dimer raises suspicion for pulmonary embolism, but this is less likely given the more prominent findings of ACS and heart failure.
Acute treatment goals include improving oxygenation, reducing preload and afterload, and addressing the underlying cause. This may involve oxygen supplementation, diuretics (e.g., furosemide), vasodilators (e.g., nitroglycerin), and management of ACS with antiplatelet agents, anticoagulants, and potentially revascularization.
To prevent future episodes, focus on managing underlying conditions, including hypertension, hyperlipidemia, diabetes, and coronary artery disease. This involves lifestyle modifications (diet, exercise, smoking cessation), medication adherence, and regular follow-up with healthcare providers. Addressing sleep apnea, if present, can also improve outcomes.
Key points
- Dyspnea requires a multi-systemic differential diagnosis.
- Key diagnostic studies are essential for evaluating dyspnea.
- Pathophysiology should be correlated with patient presentation to guide treatment.
- Consider cardiac, pulmonary, and other systemic causes of dyspnea.
- Important lab values include cardiac enzymes, BNP, and D-dimer.
- Acute treatment focuses on stabilizing the patient and addressing the underlying cause.
- Secondary prevention strategies are crucial to prevent future episodes.